DurgicalDurgical
EN
Open the app

Suvorexant !

An orexin receptor antagonist for insomnia. It blocks the brain's wake signal; it can cause next-day drowsiness and brief paralysis on falling asleep.

Updated 2026-11-01

The figure shows suvorexant itself bound to the human OX2 orexin receptor; it also blocks OX1.

Target in 3D: Orexin receptor type 2 (OX2). PDB structure 4S0V (RCSB PDB, public domain). View the structure at RCSB PDB

Mechanism of action

Orexins are neuropeptides from the hypothalamus that keep the brain awake. Suvorexant blocks orexin 1 and orexin 2 receptors, turning down this wake drive so that sleep can begin and continue, without acting on GABA-A receptors.

  1. Orexin from the hypothalamus keeps the brain awake
  2. Suvorexant blocks orexin 1 and 2 receptors
  3. The wake drive falls: sleep starts and lasts

Pharmacokinetics

Absorption
Given by mouth shortly before bed

Indications

Adverse effects

Common

  • Drowsiness and next-day sleepiness
  • Headache and dizziness
  • Unusual dreams

Contraindications

  • Narcolepsy (generally avoided)
  • Hypersensitivity to suvorexant

Key interactions

Alcohol
Worse side effects; avoided
Grapefruit and grapefruit juice
May change its effect; discussed with the prescriber

What is monitored

  • Next-day alertness and falls
  • Mood and suicidal thoughts
  • Episodes of sleep paralysis or sudden leg weakness

Administration and safety

  • Given by mouth shortly before bed, only when a full night in bed is possible
  • Controlled medicine

Nursing care

  • Check how the person slept, next-morning alertness and falls
  • Ask about alcohol and other sedatives
  • Teach to take it only when a full night in bed is possible and not to drive the next morning if drowsy
  • Teach to report sleepwalking, sleep-driving or other actions done while not fully awake

Pregnancy and breastfeeding

Data in pregnancy are limited; plans for pregnancy or breastfeeding are discussed with the prescriber.

Test yourself

Think of the answer, then tap the question to see it.

What does the suffix -orexant indicate?

An orexin receptor antagonist.

Why is suvorexant generally avoided in narcolepsy?

Narcolepsy is linked to orexin loss; blocking orexin further could worsen it.

Which unusual effect on waking can suvorexant cause?

Brief inability to move or speak (sleep paralysis).

Add to my cards (3)

← Back to the class: Other hypnotics (melatonin agonists and orexin antagonists)

Educational content on how drugs work; not a prescribing guide and no substitute for a health professional's advice. No doses are given.

Sources: Suvorexant: MedlinePlus Drug Information (MedlinePlus (U.S. National Library of Medicine), 2026); Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed., ch. 22 (McGraw Hill, 2023); ATCDDD - ATC/DDD Index (WHO Collaborating Centre for Drug Statistics Methodology, 2026); 4S0V: Crystal structure of the human OX2 orexin receptor bound to the insomnia drug Suvorexant (RCSB Protein Data Bank, 2015).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.